These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27983793)

  • 41. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1.
    Garg NK; Tyagi RK; Singh B; Sharma G; Nirbhavane P; Kushwah V; Jain S; Katare OP
    Int J Pharm; 2016 Feb; 499(1-2):301-320. PubMed ID: 26768725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of remote film loading methodology to entrap sirolimus into liposomes: preparation, characterization and in vivo efficacy for treatment of restenosis.
    Haeri A; Sadeghian S; Rabbani S; Anvari MS; Boroumand MA; Dadashzadeh S
    Int J Pharm; 2011 Jul; 414(1-2):16-27. PubMed ID: 21554939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro/in vivo behavior.
    Esposito E; Cortesi R; Drechsler M; Fan J; Fu BM; Calderan L; Mannucci S; Boschi F; Nastruzzi C
    Eur J Pharm Biopharm; 2017 Jun; 115():285-296. PubMed ID: 28412473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral Delivery of Methylthioadenosine to the Brain Employing Solid Lipid Nanoparticles: Pharmacokinetic, Behavioral, and Histopathological Evidences.
    Kumar P; Sharma G; Gupta V; Kaur R; Thakur K; Malik R; Kumar A; Kaushal N; Katare OP; Raza K
    AAPS PharmSciTech; 2019 Jan; 20(2):74. PubMed ID: 30631981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
    Joshi G; Kumar A; Sawant K
    Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A thermosensitive chitosan hydrogel: An attempt for the nasal delivery of dimethyl fumarate.
    Nieto González N; Rassu G; Cossu M; Catenacci L; Sorrenti ML; Cama ES; Serri C; Giunchedi P; Gavini E
    Int J Biol Macromol; 2024 Oct; 278(Pt 4):134908. PubMed ID: 39181356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.
    Schulze-Topphoff U; Varrin-Doyer M; Pekarek K; Spencer CM; Shetty A; Sagan SA; Cree BA; Sobel RA; Wipke BT; Steinman L; Scannevin RH; Zamvil SS
    Proc Natl Acad Sci U S A; 2016 Apr; 113(17):4777-82. PubMed ID: 27078105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation of andrographolide-loaded solid lipid nanoparticles and their in vitro and in vivo evaluations: characteristics, release, absorption, transports, pharmacokinetics, and antihyperlipidemic activity.
    Yang T; Sheng HH; Feng NP; Wei H; Wang ZT; Wang CH
    J Pharm Sci; 2013 Dec; 102(12):4414-25. PubMed ID: 24166599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide.
    Zhang T; Chen J; Zhang Y; Shen Q; Pan W
    Eur J Pharm Sci; 2011 Jun; 43(3):174-9. PubMed ID: 21530654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
    Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
    Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer.
    Devkar TB; Tekade AR; Khandelwal KR
    Colloids Surf B Biointerfaces; 2014 Oct; 122():143-150. PubMed ID: 25033434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A cell-mimicking platelet-based drug delivery system as a potential carrier of dimethyl fumarate for multiple sclerosis.
    Mehdi-Alamdarlou S; Ahmadi F; Azadi A; Shahbazi MA; Heidari R; Ashrafi H
    Int J Pharm; 2022 Sep; 625():122084. PubMed ID: 35944590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Compounded Formulations of Dimethyl Fumarate Show Significant Variability in Product Characteristics.
    Boulas P
    Drug Res (Stuttg); 2016 May; 66(5):275-8. PubMed ID: 26697892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo pharmacokinetic studies and intracellular delivery of methotrexate by means of glycine-tethered PLGA-based polymeric micelles.
    Madhwi ; Kumar R; Kumar P; Singh B; Sharma G; Katare OP; Raza K
    Int J Pharm; 2017 Mar; 519(1-2):138-144. PubMed ID: 28093326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.
    Ranpise NS; Korabu SS; Ghodake VN
    Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dimethyl fumarate for treating relapsing multiple sclerosis.
    Sheremata W; Brown AD; Rammohan KW
    Expert Opin Drug Saf; 2015 Jan; 14(1):161-70. PubMed ID: 25382392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mucoadhesive nanostructured lipid carriers (NLCs) as potential carriers for improving oral delivery of curcumin.
    Chanburee S; Tiyaboonchai W
    Drug Dev Ind Pharm; 2017 Mar; 43(3):432-440. PubMed ID: 27808665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanostructured lipid carriers for the topical delivery of tretinoin.
    Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
    Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.